(Q43723227)

26 November 2017

title

Evolution of anti-HIV drug candidates. Part 1: From alpha-anilinophenylacetamide (alpha-APA) to imidoyl thiourea (ITU). (English)

1 reference

26 November 2017

Ludovici DW

1

1 reference

26 November 2017

Kukla MJ

2

1 reference

26 November 2017

Grous PG

3

1 reference

26 November 2017

Krishnan S

4

1 reference

26 November 2017

Andries K

5

1 reference

26 November 2017

de Béthune MP

6

1 reference

26 November 2017

Azijn H

7

1 reference

26 November 2017

Pauwels R

8

1 reference

26 November 2017

De Clercq E

9

1 reference

26 November 2017

Arnold E

10

1 reference

26 November 2017

Janssen PA

11

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

26 November 2017

published in

1 reference

26 November 2017

volume

11

1 reference

26 November 2017

issue

17

1 reference

26 November 2017

page(s)

2225-2228

1 reference

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900410-3

7 January 2021

Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin- 2(1H)-one (TIBO) derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900410-3

7 January 2021

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900410-3

7 January 2021

Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900410-3

7 January 2021

A check on rational drug design: molecular simulation of the allosteric inhibition of HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900410-3

7 January 2021

Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900410-3

7 January 2021

Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900410-3

7 January 2021

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900410-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900410-3

1 reference

7 January 2021

Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900410-3

7 January 2021

Synthesis of 2‐Pyridyl‐α‐toluenesulfonates as Antimalarials

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900410-3

7 January 2021

Evolution of anti-HIV drug candidates. Part 2: Diaryltriazine (DATA) analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900410-3

7 January 2021

10.1016/S0960-894X(01)00410-3

Identifiers

DOI

1 reference

26 November 2017

1 reference